Blood Serum Articles & Analysis
13 news found
This yields rapid and highly sensitive results, enabling researchers to detect and quantify viral RNA swiftly and accurately in a patient's blood, serum, or other relevant samples. Moreover, the kits offer unparalleled reliability, with precise and consistent performance across diverse sample types. ...
Initial preclinical data shows MV-014-212 induced a SARS-CoV-2-specific mucosal IgA response, generated serum neutralizing antibodies, and provided efficacy against challenge REDWOOD CITY, Calif., March 16, 2021 – Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent serious viral respiratory infections, announced today that the ...
Latvian COVID-19 cohort includes various types of samples (blood, serum, plasma, oropharyngeal swabs, PBMC, feces, urine, isolated DNA, RNA), molecular data (blood biochemistry, cytokine panel, genome-wide genotyping, viral genome data, metagenome, metabolome, and transcriptome data) as well as excessive characterization of each clinical case. ...
The test detects specific SARS CoV2 IgG and IgM antibodies in the blood in response to a coronavirus infection. The detection of antibodies can be used to identify those who have already had contact with the virus. ...
Glycotest is a private liver disease diagnostics company commercializing new and unique blood tests for liver cancers and fibrosis-cirrhosis. The Company’s mission is to reduce mortality and increase survival for the growing population at risk from serious liver diseases, including hepatocellular carcinoma or HCC, the most common form of liver cancer. Glycotest employs ...
Glycotest is a private liver disease diagnostics company commercializing new and unique blood tests for liver cancers and fibrosis-cirrhosis. The Company’s mission is to reduce mortality and increase survival for the growing population at risk from serious liver diseases. Glycotest employs unique non-invasive blood tests based on proprietary ...
Glycotest is a private liver disease diagnostics company commercializing new and unique blood tests for liver cancers and fibrosis-cirrhosis. The Company’s mission is to reduce mortality and increase survival for the growing population at risk from serious liver diseases. Glycotest employs unique non-invasive blood tests based on proprietary ...
Key Findings and Conclusions: Safety demonstrated by the absence of injury to skin, internal organs or blood chemistries from repeated thermal treatments in a preclinical animal model. ...
Glycotest is a private liver disease diagnostics company commercializing new and unique blood tests for liver cancers and fibrosis-cirrhosis. The Company’s mission is to reduce mortality and increase survival for the growing population at risk from serious liver diseases. Glycotest employs unique non-invasive blood tests based on proprietary ...
The extensive SpeciSafe range includes solutions for screw cap microtubes, serum vials, vacuum blood collection tubes, cryovials, Bijou containers, swabs/transport tubes and is now extended to include a pack to seal 3 Universal containers in addition to the original single Universal pack. ...
(NYSE: A) today introduced the new SureDirect Blood PCR Kit for amplification of DNA directly from blood and blood derivatives, without the need for nucleic acid extraction and isolation. This kit simplifies the DNA amplification workflow and decreases turn-around time by enabling PCR (polymerase chain reaction) directly from fresh, frozen and ...
A multi-disciplinary team of researchers evaluated blood serum samples using a technique called immunofluorescence to detect ANA in 4,754 individuals from the 1994-2004 National Health and Nutrition Examination Survey (NHANES). ...
It is the first study to use specific blood serum levels and look at food allergies across the whole life spectrum, from young children aged 1 to 5, to adults 60 and older," said Darryl Zeldin, M.D., acting clinical director at the NIH's National Institute of Environmental Health Sciences (NIEHS) and senior author on the paper. ...